Evidence map›Paper›PMID 41546817›Full record

ArticleCell biochemistry and biophysics2026

Investigating the Cellular and Tissue Response to Herbal Glucose/Cellulose-based Mesoporous Graphene Frameworks in a Rat Diabetic Wounds Model.

Parvaneh Naserzadeh, Behnaz Ashtari, Abbas Razmi, Omid Akhavan, Mahdi Rajabi, Mohamad Javad Hadi

Abstract read
PubMed Publisher
In one paragraph

Article in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Parvaneh NaserzadehColorectal Research Center, Iran University of Medical of Medical Sciences, Tehran, Iran. pnnew2011@yahoo.com.
Behnaz AshtariCellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Abbas RazmiFaculty of Engineering, Department of Mechanical Engineering, Ataturk University, Erzurum, Türkiye.
Omid AkhavanDepartment of Physics, Sharif University of Technology, P.O. Box 11155-9161, Tehran, Iran. oakhavan@sharif.edu.
Mahdi RajabiDepartment of Physics, Sharif University of Technology, P.O. Box 11155-9161, Tehran, Iran.
Mohamad Javad HadiDepartment of Medical Nanotechnology, Faculty of Advanced Technology in Medicine, Iran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus represents a major global health concern, often leading to complications such as diabetic foot ulcers. Targeted therapies that leverage cellular-level mechanisms have the potential to significantly improve treatment outcomes for these ulcers, especially in severe cases such as diabetic black foot. In recent advancements, nanotechnology has emerged as a powerful tool in wound care. Aqueous Mesoporous graphene frameworks (MGFs) were developed for the first time using a graphitization and exfoliation process applied to glucosecontaining and cellulosic herbal sources. These MGFs were utilized as glucose- containing nanomaterials to promote healing in diabetic ulcers by modulating oxidative stress responses and enhancing glutathione activity in fibroblast and keratinocyte cells derived from rat models. The core processes facilitating wound repair were linked to lipid peroxidation and the release of cytochrome c, which in turn activated caspase pathways. These results underscore the promote healing candidateof MGFs in nanomedicine, particularly as next-generation formulations such as gels or powders designed for application in the diabetic and other types of chronic wounds.

Indexed as

CelluloseDiabetes Mellitus, ExperimentalGlucoseGraphiteWound HealingAnimalsCytochromes cFibroblastsGlutathioneKeratinocytesLipid PeroxidationMaleOxidative StressPorosityRatsRats, Sprague-DawleyCelluloseCytochromes cGlucoseGlutathioneGraphiteCaspase mechanismCellulosic nanomaterialsDiabetic ulcer treatmentGraphene oxide foamsNanomedicine

Identifiers

PMID41546817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.